Intraluminal phosphate (Pi)

Intraluminal phosphate refers to the inorganic phosphorus ions present within the gastrointestinal tract, primarily originating from dietary intake and biliary secretions [StatPearls, 2023]. In healthy individuals, phosphate is absorbed into the systemic circulation to support bone mineralization and cellular energy processes, but in patients with chronic kidney disease (CKD), impaired renal excretion leads to hyperphosphatemia [NIH, 2014]. This condition is a major driver of secondary hyperparathyroidism and vascular calcification, significantly increasing cardiovascular risk [PubMed, PMID: 15506915]. Therapeutic intervention involves the use of phosphate binders, such as sevelamer or lanthanum carbonate, which are non-absorbable agents that chemically or physically sequester phosphate in the gut lumen [PubChem]. By forming insoluble complexes, these binders prevent systemic absorption and facilitate the fecal excretion of phosphorus. Some of these agents, particularly anion exchange resins, also bind other anionic small molecules like bile acids, which can be leveraged to treat hypercholesterolemia or pruritus [Mayo Clinic, 2023].

Other names

Dietary phosphateIntestinal phosphateLuminal anionsBile acidsGastrointestinal phosphateIntraluminal phosphate and other anionic small molecules

Physical sequestration and chemical binding of anions within the gastrointestinal lumen to prevent systemic absorption and facilitate fecal excretion.